Stay updated on Exenatide in Adolescent Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Exenatide in Adolescent Type 2 Diabetes Clinical Trial page.

Latest updates to the Exenatide in Adolescent Type 2 Diabetes Clinical Trial page
- Check3 days agoChange DetectedA site-wide notice regarding government funding and operation status is now visible, and the page revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check10 days agoChange DetectedGlossary toggle added; capitalization refinements for QC-related labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and a revision tag update from v3.3.4 to v3.4.0. These changes are cosmetic and administrative rather than substantive to the study details.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe interface now lists Revision: v3.3.4 and removes v3.3.3; study details appear unchanged.SummaryDifference0.0%

- Check46 days agoChange DetectedExpanded the study locations to list individual state sites (AL, AZ, CA, CO, FL, GA, IL, IN, KS, MI, MO, NV, NY, NC, OK, TN, TX, WA) instead of the previous grouped locations. The page revision label was updated to v3.3.3.SummaryDifference1%

- Check74 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the site. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedRemoval of the government funding lapse notice banner; this is an administrative update and does not affect the study details or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Exenatide in Adolescent Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exenatide in Adolescent Type 2 Diabetes Clinical Trial page.